Cosmax NBT
코스맥스엔비티 · 222040
Consumer Staples Food & Beverage · KOSDAQ
Market cap US$110.2M (₩152B)
Overview
Cosmax NBT makes health supplements, vitamins, probiotics, and functional nutrition products, that consumers take to support their wellbeing.
It supplies these products to brand-owner customers across dozens of countries, acting as a contract developer and manufacturer rather than a consumer-facing brand itself. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from overseas markets, with production facilities in Korea and Australia and a sales operation in the United States.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$241.8M
- FY2024US$230.4M
- FY2025US$208.3M
Operating profit
- FY2023US$8.7M
- FY2024US$7.2M
- FY2025US$2.9M
Net income
- FY2023−US$4.2M
- FY2024−US$3.9M
- FY2025−US$10.9M
Key ratios (FY2025)
Why it matters
The company claims to be the first Korean health-supplement firm to build a multi-country production network, with manufacturing entities in Korea and Australia and a sales entity in the US.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?